CLOS
CASI

Compagnie Lombard Odier SCmA’s CASI Pharmaceuticals CASI Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-602
Closed -$11K – 878
2014
Q1 		$11K Hold
602
– – ﹤0.01% 818
2013
Q4 		$10K Buy
+602
New +$10.2K ﹤0.01% 806

Other funds holding CASI

WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Compagnie Lombard Odier SCmA's CASI Position: Q2 2014 in Review

Compagnie Lombard Odier SCmA sold out of CASI Pharmaceuticals (CASI) in Q2 2014, closing a stake of 602 shares — an estimated $11K sold.

Compagnie Lombard Odier SCmA first reported a position in CASI in Q4 2013 and held it in 2 quarters. The position peaked at $11K in Q1 2014. 6 funds tracked by Wall St. Rank hold CASI as of Q2 2014.

  • Compagnie Lombard Odier SCmA reported no remaining CASI Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 602 CASI Pharmaceuticals shares in Q2 2014, an estimated $11K.
  • Compagnie Lombard Odier SCmA first reported a position in CASI Pharmaceuticals in Q4 2013 and held it in 2 quarters.
  • Compagnie Lombard Odier SCmA's CASI Pharmaceuticals position peaked at $11K in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2014.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2014, filed 14 Aug 2014.